Literature DB >> 21739304

Surgery for liver metastases originating from sarcoma-case series.

Maximilian Zacherl1, Gerwin A Bernhardt, Johannes Zacherl, Gerald Gruber, Peter Kornprat, Heinz Bacher, Hans-Jörg Mischinger, Reinhard Windhager, Raimund Jakesz, Thomas Grünberger.   

Abstract

INTRODUCTION: Liver metastases originating from various types of sarcoma are a rare reason for hepatic resection. So far, even multicentre studies do hardly provide statistically relevant sample sizes. Thus, review of available data can provide surgeons with useful information in similar cases. Therefore, this study can be regarded more as a contribution to this pool of data than as a stand-alone paper. PATIENTS AND METHODS: The study includes 10 women and five men who underwent subtotal hepatic resection for solitary (n = 4) and multiple (n = 11) liver metastases originating from sarcoma. The median tumour diameter was 60 mm (range 20-200 mm).
RESULTS: Morbidity was 33%. One patient died within 30 days after surgery. Resection was complete (R0) in 67%. Median overall survival was 33.6 months, 5-year survival 27%. The use of Pringle manoeuvre was significantly associated with poorer outcome (p = 0.014) and shorter period of recurrence-free survival (p = 0.012). Diameter of liver lesion over 50 mm showed significantly shorter recurrence-free survival (p = 0.042).
CONCLUSION: Hepatic resection may be beneficial in patients with isolated sarcoma metastasis in the liver.

Entities:  

Mesh:

Year:  2011        PMID: 21739304     DOI: 10.1007/s00423-011-0821-8

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  38 in total

1.  Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.

Authors:  M Van Glabbeke; A T van Oosterom; J W Oosterhuis; H Mouridsen; D Crowther; R Somers; J Verweij; A Santoro; J Buesa; T Tursz
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

2.  Metastectomy for non-colorectal, non-neuroendocrine liver secondaries.

Authors:  Melissa C Teo; Yu-Meng Tan; Alex Y Chung; Pierce K Chow; Peng C Cheow; Khee-Chee C Soo; Siew W Hee; London L Ooi
Journal:  ANZ J Surg       Date:  2006-07       Impact factor: 1.872

3.  Hepatic metastases from leiomyosarcoma: A single-center experience with 34 liver resections during a 15-year period.

Authors:  H Lang; K T Nussbaum; P Kaudel; N Frühauf; P Flemming; R Raab
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

4.  Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival.

Authors:  K G Billingsley; M E Burt; E Jara; R J Ginsberg; J M Woodruff; D H Leung; M F Brennan
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

5.  Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis.

Authors:  Srinevas K Reddy; Andrew S Barbas; Carlos E Marroquin; Michael A Morse; Paul C Kuo; Bryan M Clary
Journal:  J Am Coll Surg       Date:  2007-03       Impact factor: 6.113

6.  Cryoablation and liver resection for noncolorectal liver metastases.

Authors:  John D Goering; David M Mahvi; John E Niederhuber; Deb Chicks; Layton F Rikkers
Journal:  Am J Surg       Date:  2002-04       Impact factor: 2.565

7.  Survival after liver resection for secondary tumors.

Authors:  J H Foster
Journal:  Am J Surg       Date:  1978-03       Impact factor: 2.565

8.  Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy.

Authors:  R Smith; Y Pak; W Kraybill; J M Kane
Journal:  Eur J Surg Oncol       Date:  2008-02-21       Impact factor: 4.424

9.  Gastrointestinal leiomyosarcoma metastatic to the liver. Durable tumor regression by hepatic chemoembolization infusion with cisplatin and vinblastine.

Authors:  G M Mavligit; A A Zukwiski; L M Ellis; V P Chuang; S Wallace
Journal:  Cancer       Date:  1995-04-15       Impact factor: 6.860

10.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

Authors:  George D Demetri; Margaret von Mehren; Charles D Blanke; Annick D Van den Abbeele; Burton Eisenberg; Peter J Roberts; Michael C Heinrich; David A Tuveson; Samuel Singer; Milos Janicek; Jonathan A Fletcher; Stuart G Silverman; Sandra L Silberman; Renaud Capdeville; Beate Kiese; Bin Peng; Sasa Dimitrijevic; Brian J Druker; Christopher Corless; Christopher D M Fletcher; Heikki Joensuu
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

View more
  5 in total

Review 1.  The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review.

Authors:  Timothy L Fitzgerald; Jason Brinkley; Shannon Banks; Nasreen Vohra; Zachary P Englert; Emmanuel E Zervos
Journal:  Langenbecks Arch Surg       Date:  2014-08-23       Impact factor: 3.445

2.  Liver Resection for Hepatic Metastases from Soft Tissue Sarcoma: A Nationwide Study.

Authors:  Frederike A B Grimme; Maarten F J Seesing; Richard van Hillegersberg; Frits van Coevorden; Koert P de Jong; Iris D Nagtegaal; Cornelis Verhoef; Johannes H W de Wilt
Journal:  Dig Surg       Date:  2018-09-25       Impact factor: 2.588

Review 3.  Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature.

Authors:  Flavia Neri; Giorgio Ercolani; Paolo Di Gioia; Massimo Del Gaudio; Antonio Daniele Pinna
Journal:  Updates Surg       Date:  2015-08-08

4.  Incidence, treatment and outcome of abdominal metastases in extremity soft tissue sarcoma: Results from a multi-centre study.

Authors:  Maria A Smolle; Angelika Schaffler; Andreas Leithner; Veroniek M Van Praag; Marko Bergovec; Joanna Szkandera; Bernadette Liegl-Atzwanger; Maya Niethard; Per-Ulf Tunn; Michiel Van De Sande; Dimosthenis Andreou
Journal:  J Surg Oncol       Date:  2020-01-31       Impact factor: 3.454

Review 5.  Metastasectomy in Leiomyosarcoma: A Systematic Review and Pooled Survival Analysis.

Authors:  Megan Delisle; Bader Alshamsan; Kalki Nagaratnam; Denise Smith; Ying Wang; Amirrtha Srikanthan
Journal:  Cancers (Basel)       Date:  2022-06-21       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.